Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies

British Journal of Haematology

Volumn 130, Issue 6, 2005, Pages 852-859

  De Graaf, Aniek O ^a,b   Han Van Krieken, J ^a   Tönnissen, Evelyn ^a   Wissink, Willemijn ^a   Van De Locht, Louis ^a   Overes, Ingrid ^a   Dolstra, Harry ^a   De Witte, Theo ^a   Van Der Reijden, Bert A ^a   Jansen, Joop H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Bcl 2 family; Inhibitors of apoptosis; Leukaemia; Lymphoma

Indexed keywords

PROTEIN; PROTEIN BCL 2; PROTEIN C IAP1; PROTEIN C IAP2; SURVIVIN; UNCLASSIFIED DRUG; BIRC2 PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; METABOLISM; METHODOLOGY; POLYMERASE CHAIN REACTION;

APOPTOSIS; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LEUKEMIA, LYMPHOCYTIC; LYMPHOMA, NON-HODGKIN; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 27244436272     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05690.x     Document Type: Article

References (30)

1. Alizadeh A.A. Eisen M.B. Davis R.E. Ma C. Lossos I.S. Rosenwald A. Boldrick J.C. Sabet H. Tran T. Yu X. Powell J.I. Yang L. Marti G.E. Moore T. Hudson Jr., J. Lu L. Lewis D.B. Tibshirani R. Sherlock G. Chan W.C. Greiner T.C. Weisenburger D.D. Armitage J.O. Warnke R. Levy R. Wilson W. Grever M.R. Byrd J.C. Botstein D. Brown P.O. Staudt L.M. ( 2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503 511.
2. Altieri D.C. ( 2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 22, 8581 8589.
3. Ambrosini G. Adida C. Altieri D.C. ( 1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Medicine, 3, 917 921.
4. Caligaris-Cappio F. Hamblin T.J. ( 1999) B-cell chronic lymphocytic leukemia: a bird of a different feather. Journal of Clinical Oncology, 17, 399 408.
5. Cory S. Adams J.M. ( 2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nature Reviews Cancer, 2, 647 656.
6. Dave S.S. Wright G. Tan B. Rosenwald A. Gascoyne R.D. Chan W.C. Fisher R.I. Braziel R.M. Rimsza L.M. Grogan T.M. Miller T.P. LeBlanc M. Greiner T.C. Weisenburger D.D. Lynch J.C. Vose J. Armitage J.O. Smeland E.B. Kvaloy S. Holte H. Delabie J. Connors J.M. Lansdorp P.M. Ouyang Q. Lister T.A. Davies A.J. Norton A.J. Muller-Hermelink H.K. Ott G. Campo E. Montserrat E. Wilson W.H. Jaffe E.S. Simon R. Yang L. Powell J. Zhao H. Goldschmidt N. Chiorazzi M. Staudt L.M. ( 2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. New England Journal of Medicine, 351, 2159 2169.
7. Dierlamm J. Baens M. Wlodarska I. Stefanova-Ouzounova M. Hernandez J.M. Hossfeld D.K. De Wolf-Peeters C. Hagemeijer A. Van den B.H. Van den Berghe H. Marynen P. ( 1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood, 93, 3601 3609.
8. Du C. Fang M. Li Y. Li L. Wang X. ( 2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102, 33 42.
9. Eisen M.B. Spellman P.T. Brown P.O. Botstein D. ( 1998) Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Science of the United States of America 95, 14863 14868.
10. Giodini A. Kallio M.J. Wall N.R. Gorbsky G.J. Tognin S. Marchisio P.C. Symons M. Altieri D.C. ( 2002) Regulation of microtubule stability and mitotic progression by survivin. Cancer Research, 62, 2462 2467.
11. de Graaf A.O. de Witte T. Jansen J.H. ( 2004) Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer Leukemia, 18, 1751 1759.
12. Granziero L. Ghia P. Circosta P. Gottardi D. Strola G. Geuna M. Montagna L. Piccoli P. Chilosi M. Caligaris-Cappio F. ( 2001) Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood, 97, 2777 2783.
13. Jacobson J.O. Wilkes B.M. Kwaiatkowski D.J. Medeiros L.J. Aisenberg A.C. Harris N.L. ( 1993) bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Cancer, 72, 231 236.
14. Jelinek D.F. Tschumper R.C. Stolovitzky G.A. Iturria S.J. Tu Y. Lepre J. Shah N. Kay N.E. ( 2003) Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Molecular Cancer Research, 1, 346 361.
15. Klein U. Tu Y. Stolovitzky G.A. Mattioli M. Cattoretti G. Husson H. Freedman A. Inghirami G. Cro L. Baldini L. Neri A. Califano A. Dalla-Favera R. ( 2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. Journal of Experimental Medicine, 194, 1625 1638.
16. Liston P. Fong W.G. Korneluk R.G. ( 2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene, 22, 8568 8580.
17. Mackus W.J. Kater A.P. Grummels A. Evers L.M. Hooijbrink B. Kramer M.H. Castro J.E. Kipps T.J. van Lier R.A. van Oers M.H. Eldering E. ( 2005) Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation. Leukemia, 19, 427 434.
18. Munzert G. Kirchner D. Stobbe H. Bergmann L. Schmid R.M. Dohner H. Heimpel H. ( 2002) Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis. Blood, 100, 3749 3756.
19. Opferman J.T. Korsmeyer S.J. ( 2003) Apoptosis in the development and maintenance of the immune system. Nature Immunology, 4, 410 415.
20. Rathmell J.C. Thompson C.B. ( 2002) Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell, 109 ( Suppl. S97 S107.
21. Reed J.C. ( 1998) Molecular biology of chronic lymphocytic leukemia: implications for therapy. Seminars in Hematology, 35, 3 13.
22. Rosenwald A. Alizadeh A.A. Widhopf G. Simon R. Davis R.E. Yu X. Yang L. Pickeral O.K. Rassenti L.Z. Powell J. Botstein D. Byrd J.C. Grever M.R. Cheson B.D. Chiorazzi N. Wilson W.H. Kipps T.J. Brown P.O. Staudt L.M. ( 2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. Journal of Experimental Medicine, 194, 1639 1647.
23. Rosenwald A. Wright G. Chan W.C. Connors J.M. Campo E. Fisher R.I. Gascoyne R.D. Muller-Hermelink H.K. Smeland E.B. Giltnane J.M. Hurt E.M. Zhao H. Averett L. Yang L. Wilson W.H. Jaffe E.S. Simon R. Klausner R.D. Powell J. Duffey P.L. Longo D.L. Greiner T.C. Weisenburger D.D. Sanger W.G. Dave B.J. Lynch J.C. Vose J. Armitage J.O. Montserrat E. Lopez-Guillermo A. Grogan T.M. Miller T.P. LeBlanc M. Ott G. Kvaloy S. Delabie J. Holte H. Krajci P. Stokke T. Staudt L.M. ( 2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 1937 1947.
24. Rosenwald A. Wright G. Wiestner A. Chan W.C. Connors J.M. Campo E. Gascoyne R.D. Grogan T.M. Muller-Hermelink H.K. Smeland E.B. Chiorazzi M. Giltnane J.M. Hurt E.M. Zhao H. Averett L. Henrickson S. Yang L. Powell J. Wilson W.H. Jaffe E.S. Simon R. Klausner R.D. Montserrat E. Bosch F. Greiner T.C. Weisenburger D.D. Sanger W.G. Dave B.J. Lynch J.C. Vose J. Armitage J.O. Fisher R.I. Miller T.P. LeBlanc M. Ott G. Kvaloy S. Holte H. Delabie J. Staudt L.M. ( 2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell, 3, 185 197.
25. Sanz L. Garcia-Marco J.A. Casanova B. de La Fuente M.T. Garcia-Gila M. Garcia-Pardo A. Silva A. ( 2004) Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells. Biochemical and Biophysical Research Communications, 315, 562 567.
26. Shipp M.A. Ross K.N. Tamayo P. Weng A.P. Kutok J.L. Aguiar R.C. Gaasenbeek M. Angelo M. Reich M. Pinkus G.S. Ray T.S. Koval M.A. Last K.W. Norton A. Lister T.A. Mesirov J. Neuberg D.S. Lander E.S. Aster J.C. Golub T.R. ( 2002) Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nature Medicine, 8, 68 74.
27. Staudt L.M. ( 2003) Molecular diagnosis of the hematologic cancers. New England Journal of Medicine, 348, 1777 1785.
28. Tsujimoto Y. Croce C.M. ( 1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proceedings of the National Academy of Science of the United States of America, 83, 5214 5218.
29. Verhagen A.M. Ekert P.G. Pakusch M. Silke J. Connolly L.M. Reid G.E. Moritz R.L. Simpson R.J. Vaux D.L. ( 2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102, 43 53.
30. Wang X. ( 2001) The expanding role of mitochondria in apoptosis. Genes and Development, 15, 2922 2933.